Gentamicin

Half-Life (t½)
IV: 2h · IM: 2h
Formula
C21H43N5O7
Molecular Weight
477.6 g/mol
PubChem CID
3467

Pharmacological Mechanism

Aminoglycoside — binds bacterial 30S ribosome at A-site, causes misreading + premature chain termination. Concentration-dependent killing → once-daily extended-interval dosing. Nephrotoxicity + ototoxicity (cochlear + vestibular) require trough monitoring + audiometry.

Half-Life & Elimination Curve (IV: 2h · IM: 2h)

100%50%25%12.5%0%0h0×t½2h1×t½4h2×t½6h3×t½8h4×t½10h5×t½0×t½ (0h): 100% remaining (~17.1 mg/L)1×t½ (2h): 50% remaining (~8.57 mg/L)2×t½ (4h): 25% remaining (~4.29 mg/L)3×t½ (6h): 12.5% remaining (~2.14 mg/L)4×t½ (8h): 6.3% remaining (~1.07 mg/L)5×t½ (10h): 3.1% remaining (~0.536 mg/L)
Elimination (IV)
  • 0×t½0h100% (17.1 mg/L)
  • 1×t½2h50% (8.57 mg/L)
  • 2×t½4h25% (4.29 mg/L)
  • 3×t½6h12.5% (2.14 mg/L)
  • 4×t½8h6.3% (1.07 mg/L)
  • 5×t½10h3.1% (0.536 mg/L)
Elimination t½2h (IV)
Rate Constant (ke)0.347 h⁻¹
Est. Peak (Cmax)17.1 mg/L
Clearance (CL)4.85 L/h
97% Washout (5×t½)10h

Dosing Guidelines

Pharmacokinetic Parameters

Pathways It Modulates

Target Organ Systems

Chemical Structure & Identifiers

References